Frank dela Rama is a prostate cancer nurse navigator and advanced oncology clinical nurse specialist at the Palo Alto Medical Foundation (PAMF), where he has been supporting patients across Alameda, San Mateo, Santa Clara, and Santa Cruz counties in California for over 22 years. During his tenure with PAMF, he helped expand the radiation oncology nursing service, established the role of oncology nurse navigator, and created PAMF’s Cancer Genetics program, which provides genetic counseling and testing predominantly for BRCA1/2 genes (Hereditary Breast/Ovarian Cancer syndrome) and Lynch syndrome genes (Hereditary Colorectal Cancer). He is actively involved in developing additional programs and services at PAMF, including survivorship, oncology nurse navigators, a Prostate Cancer Buddy Program, and studies on cancer treatment decision-making strategies. He is also a senior oncology/cancer genetics nurse navigator for Navvisa, helping to build an innovative oncology navigation model program.
Mr. dela Rama has been serving as co-chair of the Academy of Oncology Nurse and Patient Navigators (AONN) and the Genetics/Genomics Committee since 2018. He served as president of the board of directors for Breast Cancer Connections, a nonprofit organization located in the San Francisco Bay Area, offering free programs and services for those affected by breast cancer and their loved ones. He also serves on the editorial board for several oncology nursing publications, including the Journal of Oncology Navigation and Survivorship, and has written chapters for Oncology Nursing Society publications geared specifically towards navigators. He is a featured speaker on prostate cancer and genetics at conferences and events, sharing his passion for quality cancer care.
Mr. dela Rama earned a bachelor’s degree in genetics from the University of California, Davis as well as a bachelor’s degree in nursing from the University of San Francisco. He went on to complete his master’s degree at the University of California, San Francisco to become an advanced oncology clinical nurse specialist (AOCNS) in Oncology/Genomics.
Latoya G. Keglovits, MD is a hematopathologist at Pathologists Bio-Medical Laboratories and medical director of the flow cytometry laboratory at Medfusion in Dallas, Texas. She is board certified in Anatomic and Clinical Pathology by the American Board of Pathology (ABP) and Hematopathology, and is affiliated with Baylor University Medical Center. Her interests include the evaluation and diagnosis of hematolymphoid malignancies using morphologic features as well as immunohistochemistry, molecular, FISH, and cytogenetic tests results.
Dr. Keglovits holds active medical licenses in the states of Texas, Virginia, Maryland, Colorado, Minnesota, and Nevada. She is a member of the Denton County Medical Society, the North Texas Society of Pathologists, the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP).
Dr. Keglovits received her medical degree from the University of Texas Medical Branch (UTMB) School of Medicine. She completed her residency in pathology at Baylor University Medical Center in 2011 and a fellowship in hematopathology at UTMB-Galveston in 2012.
Athena Puski is a certified genetic counselor at University of Iowa Health Care and has been providing genetic counseling for individuals with all cancer types at the University’s Holden Comprehensive Cancer Center. She has helped integrate genetic counseling into a multi-disciplinary breast health clinic and has worked to assess downstream revenue generated from genetic counseling for hereditary breast cancer. She has extensive clinical experience working with various cancer types, including breast, gynecologic, gastrointestinal, neuroendocrine, renal, hematologic, and skin. She serves as the cancer center’s genetic counseling liaison for the Commission on Cancer and National Accreditation Program for Breast Cancer committees.
Ms. Puski earned a bachelor’s degree in biology and bachelor’s degree in Spanish language and literature from Central College in Pella, Iowa. She went on to earn a master’s degree in genetic counseling from Ohio State University.
Luis E. Raez, MD, FACP, FCCP is the chief scientific officer and medical director at Memorial Cancer Institute (MCI)/Memorial Health Care System. He is also the director of the Thoracic Oncology Program and co-director of the MCI/Florida Atlantic University (FAU) Florida Cancer Center of Excellence, which has been designated by the Florida Department of Health as one of only five Cancer Centers of Excellence in Florida. He serves as clinical professor of medicine at Florida International University (FIU), visiting professor of medicine at Cayetano Heredia University in Peru, and research professor at Florida Atlantic University (FAU). Dr. Raez’s clinical specialties include medical oncology in the areas of lung cancer and head and neck cancer therapy, as well as internal medicine and clinical hematology. He designs phase I-III clinical trials with new targeted agents and immunotherapy, conducts translational and clinical research in cancer vaccines, and has been funded by the National Cancer Institute (NCI) and the pharma industry.
Dr. Raez was an associate professor of medicine, epidemiology and public health, and a co-director of thoracic oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He served the president of the Florida Society of Clinical Oncology (FLASCO) from 2019-2021. He has also been serving as chairman of the International Association for the Study of Lung Cancer (IASLC) Latin American Group (LATAM) since 2018; chair of the IASLC Membership Committee from 2015-2018; international chair of the IASLC-Latin-American Meeting (LALCA) since 2014; chairman of the “Miami Best of the American Society of Clinical Oncology (ASCO)” since 2014, chair and founder of the “Miami Cancer Meeting (MCM)” since 2002, and co-chairman of the “Puerto Rico Fall Cancer Symposia (FCS)” since 2010, among many other institutions. He is one of the founding members of the Oncology Latin-American Association (OLA). He has also delivered presentations and lectures in national and international meetings across the United States, Europe, Latin America, Africa, and Asia.
Dr. Raez received his medical degree from Cayetano Heredia University in Lima, Peru. He completed residencies in hematology/oncology and internal medicine at the University of Miami. He is American Board Certified in internal Medicine and Medical Oncology, and board eligible in Hematology.
Patricia Rice is a board-certified adult nurse practitioner and board-certified advanced practice nurse in genetics. She serves as the clinical director of Precision Medicine and Genetics at Frederick Health in Frederick, Maryland. Her clinical interests include hereditary genetics, precision medicine, research, and health and wellness. Her interests also include population health initiatives that positively impact the health of the community and the emotional wellbeing of patients and families coping with genetic disorders.
Ms. Rice holds an oncology nursing certification from the Oncology Nursing Society. She is also affiliated with the International Society of Nurses in Genetics, City of Hope Community of Clinical Practice, University of Maryland Nursing School, Johns Hopkins Nursing School, and the Salisbury State University Nursing School.
Ms. Rice earned her bachelor’s degree in nursing from the Catholic University of America and her master’s degree and post-graduate degree in adult health/nursing practitioner from the University of Maryland.
Cindy Snyder is an advanced clinical genomics nurse practitioner and oncology nurse navigator for the Georgia Center for Oncology Research and Education (CORE), where she leads the genetics program and educates Georgians on family history and hereditary risk assessment to reduce the cancer burden in people with a high risk of hereditary cancer. She also coordinates the Cancer Patient Navigators of Georgia, offering education and resources to cancer patient navigators and growing the network throughout the state. She specializes in cancer risk assessment/high risk management and testing for hereditary cancer syndromes, with a focus on Hereditary Breast and Ovarian Cancer (HBOC) syndrome and Lynch syndrome.
Ms. Snyder is a board-certified family nurse practitioner through the American Association of Nurse Practitioners and served as the nurse practitioner/advanced practice nurse in genetics in the Cancer Genetics and Risk Assessment Program at Northside Hospital Gwinnett in Gwinnett County, Georgia. She completed an intensive course in cancer risk assessment at the City of Hope National Medical Center’s Department of Clinical Cancer Genetics in 2006.
In 2011, she received her doctorate of nursing practice from Union University in Jackson, Tennessee.
This project is made possible by support from AstraZeneca and Blueprint Medicines.